CAMP
CAMP4 Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology · US
$4.41
−1.78%6
Insider buys (3m)
6
Insider sells (3m)
-$2.4M
Net value (3m)
+9.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Gold Kelly · officer: Chief Financial Officer | Purchase | 10,000 | $3.96 |
| Aug 31, 2026 | Schwab Andrew J. · director | Sale | 400,000 | $4.04 |
| Aug 26, 2026 | Schwab Andrew J. · director | Sale | 10 | $4.50 |
| Aug 21, 2026 | Schwab Andrew J. · director | Sale | 45,147 | $4.76 |
| Aug 21, 2026 | Schwab Andrew J. · director | Sale | 32,018 | $4.50 |
| Aug 21, 2026 | Schwab Andrew J. · director | Sale | 114,700 | $4.54 |
| Aug 19, 2026 | Tardiff Daniel · officer: Chief Scientific Officer | Sale | 1,738 | $4.76 |
| Aug 5, 2026 | Young Richard A · director | Purchase | 16,378 | $1.65 |
| Aug 5, 2026 | 5AM Partners VI, LLC · 10 percent owner | Purchase | 3,179,558 | $0.00 |
| Aug 5, 2026 | Gold Kelly · officer: Chief Financial Officer | Purchase | 6,551 | $1.65 |
| Aug 5, 2026 | Maricich Yuri · officer: Chief Medical Officer | Purchase | 6,551 | $1.65 |
| Aug 5, 2026 | Mandel-Brehm Josh · director, officer: Chief Executive Officer | Purchase | 6,551 | $1.65 |
| Aug 5, 2026 | Schwab Andrew J. · director | A-Award | 3,179,558 | $0.00 |
| Jun 12, 2026 | WILLIAMS DOUGLAS E · director | A-Award | 28,000 | $4.34 |
| Jun 12, 2026 | Nashat Amir · director, 10 percent owner: | A-Award | 28,000 | $4.34 |
| Jun 12, 2026 | Holtzman Steven H · director | A-Award | 28,000 | $4.34 |
| Jun 12, 2026 | Young Richard A · director | A-Award | 28,000 | $4.34 |
| Jun 12, 2026 | Stewart Murray · director | A-Award | 28,000 | $4.34 |
| Jun 12, 2026 | Schwab Andrew J. · director, 10 percent owner: | A-Award | 28,000 | $4.34 |
| Apr 3, 2026 | Maricich Yuri · officer: Chief Medical Officer | A-Award | 215,000 | $4.46 |
| Apr 3, 2026 | Tardiff Daniel · officer: Chief Scientific Officer | A-Award | 170,000 | $4.46 |
| Apr 3, 2026 | Gold Kelly · officer: Chief Financial Officer | A-Award | 215,000 | $4.46 |
| Apr 3, 2026 | MacLean Michael F · director | A-Award | 56,000 | $4.46 |
| Apr 3, 2026 | Mandel-Brehm Josh · director, officer: Chief Executive Officer | A-Award | 580,000 | $4.46 |
| Dec 22, 2025 | Gold Kelly · officer: Chief Financial Officer | A-Award | 190,000 | $6.01 |
| Dec 22, 2025 | Maricich Yuri · officer: Chief Medical Officer | A-Award | 190,000 | $6.01 |
| Dec 22, 2025 | Tardiff Daniel · officer: Chief Scientific Officer | A-Award | 145,500 | $6.01 |
| Dec 22, 2025 | Mandel-Brehm Josh · director, officer: Chief Executive Officer | A-Award | 425,000 | $6.01 |
| Sep 15, 2025 | 5AM Partners VI, LLC · 10 percent owner | Purchase | 2,941,176 | $1.53 |
| Sep 15, 2025 | Schwab Andrew J. · director, 10 percent owner: | A-Award | 2,941,176 | $1.53 |
Institutional positioning
13F filings over the trailing two quarters
New 15Increased 16Reduced 9Sold out 46
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Unchanged | 6,307,636 | May 18, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Unchanged | 5,869,091 | May 15, 2026 |
| FMR LLC | Increased | 4,933,432 | May 15, 2026 |
| VIVO CAPITAL, LLC | Unchanged | 4,246,568 | May 20, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 2,632,437 | May 15, 2026 |
| ENAVATE SCIENCES GP, LLC | Reduced | 2,190,920 | May 15, 2026 |
| AH CAPITAL MANAGEMENT, L.L.C. | Unchanged | 2,125,339 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 1,960,784 | May 15, 2026 |
| Trails Edge Capital Partners, LP | Reduced | 1,939,563 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,534,768 | May 15, 2026 |
| STONEPINE CAPITAL MANAGEMENT, LLC | Increased | 1,389,622 | May 14, 2026 |
| HARBOURVEST PARTNERS LLC | Unchanged | 1,271,948 | May 15, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | New Position | 653,594 | May 14, 2026 |
| BLACKROCK, INC. | Increased | 456,371 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 382,821 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026